Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 5,947 | 6,411 | 8,354 | 7,048 | 9,084 |
| Operating Income | -5,947 | -6,411 | -8,354 | -7,048 | -9,084 |
| Other Income | 338 | 435 | 439 | 278 | 473 |
| Pre-tax Income | -5,609 | -5,976 | -7,915 | -6,770 | -8,611 |
| Net Income Continuous | -5,609 | -5,976 | -7,915 | -6,770 | -8,611 |
| Net Income | $-5,609 | $-5,976 | $-7,915 | $-6,770 | $-8,611 |
| EPS Basic Total Ops | -70.50 | -75.50 | -103.25 | -5,412.29 | -112.44 |
| EPS Basic Continuous Ops | -70.56 | -75.48 | -103.24 | -5,413.19 | -112.74 |
| EPS Diluted Total Ops | -70.50 | -75.50 | -103.25 | -5,412.29 | -112.44 |
| EPS Diluted Continuous Ops | -70.56 | -75.48 | -103.24 | -5,413.19 | -112.74 |
| EBITDA(a) | $-5,916 | $-6,380 | $-8,324 | $-7,016 | $-9,052 |